Delivery system
US8057433B2 · kind B2 · utility
15Cited by
7References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 8, 2005 |
| Grant date | Nov 15, 2011 |
| Priority date | — |
| Expiry date | Nov 17, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M31/00
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A pharmaceutical delivery system that releases an active agent in a controlled manner for an extended period in the vaginal cavity to treat or cure ailments associated with the vaginal cavity or proximal areas. The delivery system includes an applicator which is composed of a high internal phase emulsion, allowing the delivery system to adhere to the mueosal surfaces of the body, primarily the lining of vaginal cavity. The delivery system can maintain the high internal phase emulsion at a temperature of 86° F. for at least one month, without decomposition or instability of the emulsion.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.